NewsBenzingaLakewood-Amedex Biotherapeutics在IDWeek 2026上展示了强调其领先临床候选药物Nu-3抗菌特征的研究;试验顶线数据预计将于2027年第一季度公布 Lakewood-Amedex Biotherapeutics在IDWeek 2026上展示了强调其领先临床候选药物Nu-3抗菌特征的研究;试验顶线数据预计将于2027年第一季度公布 Benzinga 2026.10.21 12:07 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Kodiak AI, Lowers Price Target to $7 Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says